Clinical Trial: RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Study Status: Completed
Recruit Status: RECRUITING
Condition: Dementia With Lewy Bodies
Study Type: INTERVENTIONAL
Official Title: A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies
Brief Summary:
The purpose of this study is to determine whether neflamapimod can improve learning skills, problem solving skills, and memory loss in people diagnosed with DLB.More specifically, improvement in verbal learning, memory, and attention, as well as cognitive and functional performance will be measured.
Read more